Veraxa Biotech Holding AG director and Chief Executive Officer Christoph Rudiger Antz has filed an initial Form 3 as an insider of the company. The filing identifies his roles but does not report any transactions or share holdings, with all transaction and holding counts shown as zero.
Veraxa Biotech Holding AG officer Heinz Schwer has filed a Form 3 as Chief Business Officer of VRXA. This is an initial statement of beneficial ownership and shows no reported transactions, with no shares bought, sold, acquired, or disposed of in this filing.
Veraxa Biotech Holding AG executive Buergermeister Torsten Georg Friedrich, the company’s Chief Financial Officer, has filed an initial Form 3 as an officer of the company. The data provided does not list any reportable transactions or holdings, indicating this filing is primarily an initial ownership disclosure.